Investors

Building a Biopharmaceutical Company

Investors

Lexicon Pharmaceuticals is a biopharmaceutical company focused on developing breakthrough treatments for human disease.

Stock Quote Events & Webcasts
NASDAQ: LXRX
0.99
+0.04 (+4.21%)
Range 0.96 - 1.01
Open 0.97
Prev Close 0.95
52 Week 0.90 - 2.45
Volume 4711209
Market Cap 509.7M
*Delayed 11/24/2014 4:00 EDT

 

Investor and Media Relations Contact
Corporate Communications and Investor Relations
Lexicon Pharmaceuticals, Inc.
8800 Technology Forest Place
The Woodlands, TX 77381-1160
281.863.3000